The evolving clinical testing landscape of genomic aberrations in solid tumors and hematological malignancies - Insights from evidence-based reviews for B-ALL and breast, brain, and renal cell neoplasia

Cancer Genet. 2020 Jun:244:60-61. doi: 10.1016/j.cancergen.2020.04.001. Epub 2020 Apr 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Chromosome Aberrations*
  • Genetic Testing / methods*
  • Genomics / methods*
  • Hematologic Neoplasms / diagnosis*
  • Hematologic Neoplasms / genetics
  • Humans
  • Neoplasms / diagnosis*
  • Neoplasms / genetics
  • Prognosis

Substances

  • Biomarkers, Tumor